MedPath

Carbon Dioxide

Carbon Dioxide 130

Approved
Approval ID

21ff33df-b092-4cc6-9fe2-8e5cdc475e41

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 19, 2023

Manufacturers
FDA

Airgas Usa, LLC

DUNS: 078301808

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carbon Dioxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code11054-130
Application NumberNDA206025
Product Classification
M
Marketing Category
C73594
G
Generic Name
Carbon Dioxide
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 26, 2022
FDA Product Classification

INGREDIENTS (1)

Carbon DioxideActive
Quantity: 992 mL in 1 L
Code: 142M471B3J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carbon Dioxide - FDA Drug Approval Details